This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Stichting Vu. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Innovations of Raymond Henry De Wit
Introduction
Raymond Henry De Wit is a notable inventor based in Amsterdam, Netherlands. He has made significant contributions to the field of biotechnology, particularly in the development of novel therapeutic antibodies. His work focuses on addressing critical medical challenges, including cancer treatment.
Latest Patents
One of his key patents is titled "Inverse agonistic anti-US28 antibodies." This invention relates to a novel class of antagonistic and inverse agonistic anti-US28 antibodies, specifically single heavy chain variable domain antibodies (VHH) and their variants and modifications. The patent also covers methods for producing these antibodies and their use in diagnostic and therapeutic applications, particularly for treating individuals suffering from CMV-positive tumors such as glioblastoma.
Career Highlights
Raymond is associated with Stichting Vu, where he continues to advance his research and development efforts. His innovative work has the potential to impact the medical field significantly, especially in oncology.
Collaborations
He collaborates with talented individuals such as Martine Joyce Smit and Raimond Heukers, contributing to a dynamic research environment.
Conclusion
Raymond Henry De Wit exemplifies the spirit of innovation in biotechnology through his groundbreaking work on therapeutic antibodies. His contributions are paving the way for new treatment options in the fight against cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile